Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

InterAx Biotech

InterAx Biotech
PRIVATE STATUS
Series A LATEST DEAL TYPE
$3.04M LATEST DEAL AMOUNT
4 INVESTORS
Description

Owner and operator of a biotechnology company. The company develops drug-screening packages using membrane and soluble protein for the pharmaceutical industry.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • C/o Paul Scherrer Institute
  • OFLG, 5232 Villigen PSI
  • Switzerland

+41 056 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore InterAx Biotech’s full profile, request a free trial.

InterAx Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 15-Jan-2019 $3.04M 00.000 000.00 Completed Startup
2. Grant 20-Jun-2018 000.00 0000 Completed Startup
1. Accelerator/Incubator 01-Jan-2015 $30K $30K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

InterAx Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

InterAx Biotech Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dianomi Therapeutics Angel-Backed Madison, WI 0 00.000 000000000000 00.000
000000 Venture Capital-Backed Cambridge, MA 00 0000 000000000000 0000
000000000 00000000 Formerly VC-backed Utrecht, Netherlands 00 00.00 000000&0 00.00
00000000 Formerly VC-backed Munich, Germany 000.00 000000&0 000.00
000000 00000000000 Failed Transaction (M&A) Cambridge, MA 000 00000 000000&0
To view this company’s complete list of competitors, request access »

InterAx Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Falcon III Ventures Venture Capital Minority 000 0000 000000 0
Investiere Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Venture Kick Accelerator/Incubator Minority 000 0000 000000 0

InterAx Biotech Executive Team (1)

Name Title Board
Seat
Contact
Info
Martin Ostermaier Co-Founder, Chief Executive Officer & Board Member

InterAx Biotech Board Members (1)

Name Representing Role Since Contact
Info
Martin Ostermaier InterAx Biotech Co-Founder, Chief Executive Officer & Board Member 000 0000